Most of the data reported by Wong et al. on glutamine utilization by KRAS-mutated CRC cell lines overlapped with those reported for the rewired glutamine metabolism induced by mutated KRAS in PDAC [11,17]. The gene discussed is KRAS; the disease is colorectal carcinoma.